A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours

Clinical trial NCT04525638 · UNKNOWN

Trial details

NCT number: NCT04525638
Sponsor: Fundación de investigación HM
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumours (NET)Neuroendocrine Carcinomas (NEC)

Start date: 2020-06-29
Primary completion: 2024-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.